
Palvella Therapeutics Inc (PVLA)
NASDAQ
Fin d'année 31 Décembre 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -1.46 | -69.086 | -77.894 | -101.375 | -124.473 |
Return on Equity (%) | -8.333 | -76.181 | -87.681 | -124.726 | -462.941 |
Return on Invested Capital (%) | 1.77 | -75.901 | -56.169 | -128.107 | -176.527 |
Operating Margin (%) | N/A | -1605.379 | -1105.237 | -1880.67 | -932.597 |
Net Profit Margin (%) | N/A | -1606.069 | -1078.523 | -1880.784 | -932.661 |
Book Value Per Share | 0.002 | 1.366 | 0.744 | 1.03 | -0.217 |
Earnings Per Share | N/A | -0.52 | -0.933 | -2.912 | -1.654 |
Cash Per Share | N/A | 1.386 | 0.209 | 0.583 | 0.71 |
Working Capital Per Share | -0.008 | 1.418 | 0.704 | 0.922 | 0.872 |
Operating Profit Per Share | N/A | 0.011 | 0.026 | 0.098 | 0.121 |
EBIT Per Share | N/A | -0.52 | -0.956 | -2.911 | -1.654 |
EBITDA Per Share | N/A | -0.52 | -0.956 | -2.911 | -1.654 |
Free Cash Flow Per Share | N/A | -0.494 | -0.945 | -3.034 | -1.666 |
Fin d'année 31 Décembre 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 6,9M | 142,85M | N/A | 25,9M | N/A |
Fin d'année 31 Décembre 2024 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 | Déc 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||||
Actions en circulation | N/A | N/A | N/A | 25,9M | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | -935.366 | N/A | N/A | N/A | -210.084 | N/A | N/A | N/A |
Net Profit Margin (%) | -935.366 | N/A | N/A | N/A | -210.084 | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 31,61M |
Ratio cours/bénéfice | -0,45 |
Ratio prix/ventes | 4,1 |
Ratio prix/liquidités | 1,05 |
Ratio prix/valeur comptable | -3,43 |
Rendement de dividende | - |
Actions en circulation | 1,32M |
Volume moyen (1 semaine) | 52,39k |
Volume moyen (1 mois) | 51,67k |
Variation sur 52 semaines | 97,98% |
Plus haut sur 52 semaines | 24,80 |
Plus bas sur 52 semaines | 11,10 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales